Motzer, R. J., Escudier, B., Burotto, M., Powles, T., Apolo, A. B., Bourlon, M. T., Shah, A. Y., Porta, C., Suarez, C., Barrios, C. H., Richardet, M. E., Gurney, H., Kessler, E. R., Tomita, Y., Bedke, J., Rangwala, F. A., Askelson, M., Panzica, J., Fedorov, V., Choueiri, T. K. (2025). Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.439